Second Russian COVID vaccine approved
Russian President Vladimir Putin has announced the approval of a second coronavirus vaccine. The vaccine, EpiVacCorona, was described as a “peptide-based shot”. It was developed by biotechnology company State Research Center of Virology and Biotechnology VECTOR. Early trials of the vaccine on 100 volunteers were successful, said Putin. But the vaccine has not been subject to full safety and efficacy trials.
NPR | 3 min readRead more: Russia’s fast-track coronavirus vaccine draws outrage over safety (Nature | 5 min read, from August)
No hay comentarios:
Publicar un comentario